Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA) will release first-quarter 2026 financial results for the period ended March 31, 2026, on Thursday, May 7, 2026, before market open. A conference call to discuss results and recent business highlights is scheduled for May 7, 2026 at 8:00 a.m. EDT, with a live webcast and archived replay available via the Investors section of Akebia's website.

News Market Reaction – AKBA

+1.45%

+1.45% Session close to close

In the May 1 session, AKBA gained 1.45%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Akebia to Host Conference Call on May 7 at 8:00 a.m. EDT

CAMBRIDGE, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026, prior to the open of financial markets.

Akebia will host a conference call on Thursday, May 7, 2026, at 8:00 a.m. EDT to discuss its financial results and recent business highlights. To access the call, please register by clicking on this Registration Link, and you will be provided with dial in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time. 

A live webcast of the conference call will be available via the Investors section of Akebia’s website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia’s website at http://ir.akebia.com.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com

FAQ

When will Akebia (AKBA) report Q1 2026 results and hold its conference call?

Akebia will report Q1 2026 results on Thursday, May 7, 2026, before market open. According to the company, a conference call to discuss results and business highlights is scheduled the same day at 8:00 a.m. EDT with a live webcast available on its investor website.

How can investors access the Akebia (AKBA) May 7, 2026 conference call and webcast?

Investors can register for the conference call to receive dial-in details and join the webcast via Akebia's investor website. According to the company, registration provides dial-in information and a live webcast link with an archived replay posted afterward.

What time should I join the Akebia (AKBA) May 7 conference call to avoid delays?

Dial in at least 15 minutes before the scheduled 8:00 a.m. EDT start time to avoid delays. According to the company, early connection is encouraged to ensure timely access and to receive any participant instructions prior to the call.

Will Akebia (AKBA) provide a replay of the May 7, 2026 earnings webcast?

Yes. A webcast archive will be available after the live call in the Investors section of Akebia's website. According to the company, the online archive can be accessed via the investor site for on-demand listening following the event.

What topics will Akebia (AKBA) cover on the May 7, 2026 conference call?

The call will cover first-quarter 2026 financial results and recent business highlights. According to the company, management will discuss the reported quarter's results and provide commentary on recent corporate developments during the live webcast and call.